Back
Fulcrum Therapeutics Stock Price Chart
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
64
FULC
Fulcrum Therapeutics
Last Price:
$7.40
Seasonality Move:
36.07%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FULC is experiencing slight buying pressure.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.87 | Buy |
| 20-day SMA: | 6.94 | Buy |
| 50-day SMA: | 5.72 | Buy |
| 200-day SMA: | 4.3 | Buy |
| 8-day EMA: | 6.98 | Buy |
| 20-day EMA: | 6.77 | Buy |
| 50-day EMA: | 5.93 | Buy |
| 200-day EMA: | 5.07 | Buy |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 62.73 | Buy |
| Chaikin Money Flow: | 91413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.5 - 7.14) | Buy |
| Bollinger Bands (100): | (2.9 - 6.12) | Buy |
Fulcrum Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 7.16 while FULC 8-day simple moving average is 6.87, which is a Buy signal.
-
The stock price of FULC is 7.16 while Fulcrum Therapeutics 20-day SMA is 6.94, which makes it a Buy.
-
Fulcrum Therapeutics 50-day simple moving average is 5.72 while FULC share price is 7.16, making it a Buy technically.
-
FULC stock price is 7.16 and Fulcrum Therapeutics 200-day simple moving average is 4.30, creating a Buy signal.
FULC Technical Analysis vs Fundamental Analysis
Buy
64
Fulcrum Therapeutics (FULC)
is a Buy
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a BuyThe current Fulcrum Therapeutics [FULC] share price is $7.16. The Score for FULC is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
386.5M
Price in USD:
7.16
Share Volume:
263.4K
Fulcrum Therapeutics 52-Week Range
52-Week High:
10.13
52-Week Low:
2.32
Buy
64
Fulcrum Therapeutics (FULC)
is a Buy
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?The Fulcrum Therapeutics stock price is 7.16 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is not overvalued.
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 7.16 while FULC 8-day exponential moving average is 6.98, which is a Buy signal.
-
The stock price of FULC is 7.16 while Fulcrum Therapeutics 20-day EMA is 6.77, which makes it a Buy.
-
Fulcrum Therapeutics 50-day exponential moving average is 5.93 while FULC share price is 7.16, making it a Buy technically.
-
FULC stock price is 7.16 and Fulcrum Therapeutics 200-day simple moving average is 5.07, creating a Buy signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.02 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Fulcrum Therapeutics is a Buy
-
Fulcrum Therapeutics Relative Strength Index (RSI) is 62.73, which suggest Fulcrum Therapeutics is overbought
-
The Bollinger Bands (25) for Fulcrum Therapeutics is (6.5 - 7.14), which suggest Fulcrum Therapeutics is a Buy
-
The Bollinger Bands (100) for Fulcrum Therapeutics is (2.9 - 6.12), which suggest Fulcrum Therapeutics is a Buy
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.